{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01308",
      "entity_text" : "insulin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:AKT",
      "entity_text" : "AKT",
      "features" : [ {
        "modification_type" : "phosphorylation",
        "feature_type" : "modification"
      } ],
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Additionally, SOCS3 can inhibit PI3K / AKT phosphorylation in insulin signaling pathway to reduce hepatic insulin sensitivity XREF_BIBR, consequently suppressing forkhead transcription factor 1 (FoxO1) phosphorylation and promoting hepatic glucose production via increasing transcription of gluconeogenic enzymes XREF_BIBR.",
  "reading_complete" : "2020-08-02T13:30:25Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:27:57Z",
  "trigger" : "reduce",
  "evidence" : [ "AKT phosphorylation in insulin signaling pathway to reduce hepatic insulin" ],
  "pmc_id" : "6276304",
  "score" : 0
}